LEIDEN, Netherlands & CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced a presentation at the 3rd RNA Editing Summit held April 5-7 in Boston, MA, US.
Read more at globenewswire.comProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.